Non-Steroidal AntiInflammatory Drugs (NSAIDs)
Market
Non-Steroidal Anti-Inflammatory Drugs (NSAIDs)
Market Scope: Industry Analysis, Market Size, Growth, Trends Till 2031
Request Sample Report
Non-Steroidal Anti-Inflammatory Drugs (NSAIDs)
Market Size and Growth
The Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) market is experiencing significant growth, driven by rising pain management needs and increasing chronic conditions. The global NSAIDs market size is estimated to reach approximately $30 billion by 2025, fueled by advancements in drug formulations and expanding pharmaceutical distributions. Competitive dynamics remain robust within this sector.
Request Sample Report
Companies Covered
(Covid 19 Impact Covered)
◍ Roche (Genentech)
◍ Amgen
◍ B-MS
◍ Merck
◍ Pfizer
◍ Novartis
◍ Eli Lilly and Company
◍ Johnson & Johnson
◍ GSK
◍ Sanofi
◍ Boehringer Ingelheim
◍ Zhejiang Jiuzhou Pharmaceutical
The NSAID market features companies like Roche, Amgen, Merck, and Pfizer, developing and marketing various NSAID products. Their innovative formulations and strategic collaborations enhance market reach. For instance, Pfizer's Advil and Merck's Vioxx significantly impacted sales, driving growth with combined revenues in billions annually, bolstering overall market expansion.
Request Sample Report
Market Segmentation
By Application
Drug Store
Hospital Pharmacies
Online
Request Sample Report
By Product
Aspirin
Ibuprofen
Naproxen
Celecoxib
Others
Market Growth
Request Sample Report
$ X Billion USD
